Congratulation San Diego Lab Discovers COVID-19 Vaccine in 3 Hours, which could be available by the summer.
Brewing a DNA-based vaccine smells kind of like a college bar.
The scent of stale beer that lingers inside the second-floor lab at Inovio Pharmaceuticals comes from E. coli bacteria that grows the DNA medicine many times over and is later extracted.
Inovio research associate Joseph Fader likened the whole process to harvesting crops.
“Say your favorite fruit is strawberries, right? You like strawberries but you don’t like eating the plant, but you need the plant to grow the strawberries — so the E. coli cells are the plant,” Fader said.
And Inovio is trying to grow life-saving strawberries amid a raging storm.
As the deadly coronavirus known as COVID-19 is battering cities around the globe, including in the U.S., the company is racing to offer the world a life raft with its DNA-based vaccine. The process is faster, easier and doesn’t use the virus at all, contrary to traditional immunizations, which typically include a weakened or inactive pathogen. But no DNA-based vaccine has received regulatory approval for broad public use. Inovio researchers hope their coronavirus anecdote breaks that barrier and, in turn, could revolutionize vaccine development.
Like Our Story ? Donate to Support Us, Click Here
You want to share a story with us? Do you want to advertise with us? Do you need publicity/live coverage for product, service, or event? Contact us on WhatsApp +16477721660 or email Adebaconnector@gmail.com
